Helen E. Haysom

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The true cost of red cell transfusion for patients with myelodysplastic syndromes: A time-driven activity-based costing study.

The true cost of red cell transfusion for patients with myelodysplastic syndromes: A time-driven activity-based costing study.

Journal: British journal of haematology

Published: November 25, 2025

Intravenous versus subcutaneous immunoglobulin in patients with haematological malignancies: time-driven activity-based costing.

Intravenous versus subcutaneous immunoglobulin in patients with haematological malignancies: time-driven activity-based costing.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: September 25, 2025

The Australian and New Zealand Massive Transfusion Registry: An innovation focusing on data collection, standardisation and interoperability between healthcare systems.

The Australian and New Zealand Massive Transfusion Registry: An innovation focusing on data collection, standardisation and interoperability between healthcare systems.

Journal: Health information management : journal of the Health Information Management Association of Australia

Published: September 18, 2025

Outcomes of massive transfusion recipients administered ABO-incompatible fresh frozen plasma.

Outcomes of massive transfusion recipients administered ABO-incompatible fresh frozen plasma.

Journal: Transfusion

Published: October 09, 2024

Economic burden of sickle cell disease in Australia.

Economic burden of sickle cell disease in Australia.

Journal: Internal medicine journal

Published: July 10, 2024

Ultra-Massive Transfusion: Predictors of Occurrence and In-Hospital mortality From the Australian and New Zealand Massive Transfusion Registry (ANZ-MTR).

Ultra-Massive Transfusion: Predictors of Occurrence and In-Hospital mortality From the Australian and New Zealand Massive Transfusion Registry (ANZ-MTR).

Journal: Transfusion medicine reviews

Published: April 08, 2024

Sickle cell disease in Australia: a snapshot from the Australian Haemoglobinopathy Registry.

Sickle cell disease in Australia: a snapshot from the Australian Haemoglobinopathy Registry.

Journal: Internal medicine journal

Published: March 23, 2023

Red blood cell alloantibodies in the context of critical bleeding and massive transfusion.

Red blood cell alloantibodies in the context of critical bleeding and massive transfusion.

Journal: Blood transfusion = Trasfusione del sangue

Published: June 01, 2022

Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.

Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.

Journal: The Lancet. Haematology

Published: April 27, 2022

Age of red blood cells is not associated with in-hospital mortality in massively transfused patients.

Age of red blood cells is not associated with in-hospital mortality in massively transfused patients.

Journal: The journal of trauma and acute care surgery

Published: June 10, 2021

Is Platelet Expiring Out of Date? A Systematic Review.

Is Platelet Expiring Out of Date? A Systematic Review.

Journal: Transfusion medicine reviews

Published: June 02, 2019

The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing.

The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing.

Journal: Transfusion

Published: March 25, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026